Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects
- 1 April 2005
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 4 (4), 239-248
- https://doi.org/10.1016/s1474-4422(05)70043-0
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- The Ramsay Hunt syndrome revisited: Mediterranean myoclonus versus mitochondrial encephalomyopathy with ragged-red fibers and Baltic myoclonusActa Neurologica Scandinavica, 2009
- Antimyoclonic Effect of Levetiracetam in 13 Patients with Unverricht–Lundborg Disease: Clinical ObservationsEpilepsia, 2004
- Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expressionHuman Mutation, 2003
- Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2B) on 6p22Journal of Medical Genetics, 2003
- Advances in the genetics of progressive myoclonus epilepsyAmerican Journal of Medical Genetics, 2001
- Mutations in Sialidosis Impair Sialidase Binding to the Lysosomal Multienzyme ComplexPublished by Elsevier BV ,2001
- Familial Encephalopathy with Neuroserpin Inclusion BodiesThe American Journal of Pathology, 1999
- Evaluation of bupivacaine-induced muscle regeneration in the treatment of ptosis in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndromeEye, 1999
- Longitudinal EEG Studies in a Kindred with Lafora DiseaseEpilepsia, 1991
- Expression of cDNA encoding the human “protective protein≓ associated with lysosomal β-galactosidase and neuraminidase: Homology to yeast proteasesCell, 1988